that i do not know. my oncologist may have gotten this information by attending a world lung cancer conference in singapore last year. china may be the ones conducting the clinical trial because they are the world leaders in nsclc advancements in treatments. he only told me that a new drug is in clinical trial that will target all egfr proteins. the drug company may be called 'black diamond' because my partner has done a lot of research into the next generation of egfr targeted therapies. 'black diamond' seemingly stands alone in the advancement of this type of targeted therapy that will target all egfr proteins. this is becoming a race for a cure. whoever wins, conquers the cancer world for whatever specific type of cancer and the payoffs and profits would be enormous. teresa